Integrative Practitioner Digital Summit
ENVIRONMENTAL MEDICINE
Lead and Arsenic: Updating the Standard of Care
September 20, 2022 3:30 – 4:30pm ET ADD TO CALENDAR
Everyone knows that cardiovascular disease is the primary cause of death in North America. Few, however, realize that lead and arsenic account for almost half of cardiac mortality. Blood lead and urinary arsenic are highly predictive of not just cardiovascular disease but also cancer, stroke, diabetes, gout—the list is surprisingly long. This presentation provides an overview of the clinical impacts of lead and arsenic, how to measure monitor body load, and key strategies to decrease exposure and promote excretion/detoxification.
Learning Objectives:
- Learn the role of lead and arsenic in chronic disease.
- Understand the role of genetics in susceptibility to damage from these toxins.
- Identify methods to assess body load.
- Gain knowledge about ways to decrease exposure.
- Be able to implement protocols to decrease body load.
Speaker: Joseph Pizzorno, ND
Joseph Pizzorno, ND is a transformational leader in medicine. As founding president of Bastyr University in 1978, he coined the term “science-based natural medicine” and led Bastyr to become the first ever accredited institution in this field. This validated that health promotion rather than only disease treatment could be credibly taught, researched, and practiced. A licensed naturopathic physician, educator, researcher, and expert spokesman, he is editor-in-chief of PubMed-indexed IMCJ, board chair of the Institute for Functional Medicine, founding board member of American Herbal Pharmacopeia, and a member of the science boards of the Hecht Foundation and Bioclinic Naturals. He was appointed by Presidents Clinton and Bush to two prestigious government commissions to advise Congress on how to integrate natural medicine into healthcare. He is author or co-author of 6 textbooks (most recent “Clinical Environmental Medicine”) and eight consumer books (most recent “Healthy Bones, Healthy You” with wife, Lara).
